1383572-91-5

Basic information

• Product Name: 9-(4,6-dimethylpyrimidin-2-yl)-4-((1-methyl-4-phenyl-1H-pyrazol-3-yl)methyl)-1,4,9-triazaspiro[5.5]undecan-5-one
• Synonyms: 9-(4,6-dimethylpyrimidin-2-yl)-4-((1-methyl-4-phenyl-1H-pyrazol-3-yl)methyl)-1,4,9-triazaspiro[5.5]undecan-5-one
• CAS NO: 1383572-91-5
• Molecular Weight: 445.567
• Mol File: 1383572-91-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 9-(4,6-dimethylpyrimidin-2-yl)-4-((1-methyl-4-phenyl-1H-pyrazol-3-yl)methyl)-1,4,9-triazaspiro[5.5]undecan-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 9-(4,6-dimethylpyrimidin-2-yl)-4-((1-methyl-4-phenyl-1H-pyrazol-3-yl)methyl)-1,4,9-triazaspiro[5.5]undecan-5-one(1383572-91-5)
• EPA Substance Registry System: 9-(4,6-dimethylpyrimidin-2-yl)-4-((1-methyl-4-phenyl-1H-pyrazol-3-yl)methyl)-1,4,9-triazaspiro[5.5]undecan-5-one(1383572-91-5)

Safety Data

• Hazardous Substances Data: 1383572-91-5(Hazardous Substances Data)

Upstream product

• 1383575-45-8 4-bromo-3-(bromomethyl)-1-methyl-1H-pyrazole 
• 1383575-42-5 tert-butyl 9-(4,6-dimethylpyrimidin-2-yl)-5-oxo-1,4,9-triazaspiro[5.5]undecane-1-carboxylate 
• 1383575-46-9 tert-butyl 4-((4-bromo-1-methyl-1H-pyrazol-3-yl)methyl)-9-(4,6-dimethylpyrimidin-2-yl)-5-oxo-1,4,9-triazaspiro[5.5]undecane-1-carboxylate 
• 1383575-14-1 tert-butyl 9-benzyl-5-oxo-1,4,9-triazaspiro[5.5]undecane-1-carboxylate 
• 1383575-13-0 methyl 1-benzyl-4-((2-((tert-butoxycarbonyl)amino)ethyl)amino)piperidine-4-carboxylate 
• 1274752-07-6 9-benzyl-1,4,9-triazaspiro[5.5]undecan-5-one 
• 1383575-15-2 tert-butyl 5-oxo-1,4,9-triazaspiro[5.5]undecane-1-carboxylate 
• 57611-57-1 methyl 4-amino-1-benzylpiperidine-4-carboxylate 
• 211738-66-8 4-bromo-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester 
• 915707-65-2 (4-bromo-1-methyl-1H-pyrazol-3-yl)methanol 

Relevant articles and documents

DI/TRI-AZA-SPIRO-C9-C11ALKANES

The invention relates to compounds of the formula I A-D-C(R1)2-B (I), in which A and B are aromatic ring systems and wherein D is selected from the groups D1 to D5 and the other substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.